Fetal rat development as influenced by maternal lead exposure

Area of Science:

• Toxicology
• Developmental Biology
• Environmental Health

Background:

• Lead exposure is a significant public health concern, particularly for pregnant women and developing fetuses.
• Lead is a known teratogen and neurotoxin, but its specific effects on fetal development at varying exposure levels require further investigation.

Purpose of the Study:

• To investigate the teratogenic and neurologic effects of lead acetate on fetal rat development.
• To determine the impact of maternal lead acetate exposure on maternal and fetal organ lead content.
• To assess the relationship between maternal lead exposure and conceptus weight and fetal brain development.

Main Methods:

• Thirty-six female hooded rats were divided into four groups and administered daily oral doses of lead acetate (0, 50, 75, 100 mg/kg) for 3 weeks pre-breeding and throughout gestation.
• Maternal blood lead concentrations were monitored, and animals were euthanized at day 20 of gestation.
• Maternal kidney and liver, as well as fetal kidney and brain, tissues were analyzed for lead content. Conceptus weight was also measured.

Main Results:

• Maternal blood lead concentrations were maintained in treated dams throughout gestation.
• Significant lead accumulation was observed in maternal kidneys and livers, as well as in fetal kidneys of exposed groups (p < .01).
• Conceptus weight was significantly reduced in lead-exposed groups, but no teratogenic effects or reduction in fetal brain DNA content were observed.

Conclusions:

• Lead acetate readily crosses the placenta in rats, leading to significant accumulation in maternal and fetal tissues.
• Despite placental transfer and accumulation, lead acetate did not induce teratogenic effects or alter fetal brain DNA content in this study.
• These findings suggest that while lead exposure affects fetal growth, it may not cause overt malformations or neurodevelopmental deficits at the tested doses in rats.